DermTech, Inc. (DMTKQ) vs T2 Biosystems, Inc. (TTOO)

DermTech, Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $3.3M — 2.0× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −30.2%. T2 Biosystems, Inc. has the higher net margin (−559.5% vs −572.2%) and the higher return on invested capital (0.00% vs −5,493.5%). Across the 14 metrics below, DermTech, Inc. leads on 7 and T2 Biosystems, Inc. on 7.

Valuation

Metric DMTKQ TTOO Diagnostics & Research median
P/E n/m n/m 34.52
P/S n/m n/m 4.24
P/B n/m n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA 0.45 n/m 23.44
EV/Sales (2.49) 6.26 5.18
Earnings yield 0.00% 0.00% (1.50%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric DMTKQ TTOO Diagnostics & Research median
Gross margin 8.51% (76.76%) 48.32%
Operating margin (588.62%) (542.59%) (5.68%)
Net margin (572.19%) (559.52%) (4.10%)
Free cash flow margin (460.10%) (476.64%) 0.00%
Return on equity (121.75%) 277.61% 0.00%
Return on assets (64.00%) (140.00%) (6.05%)
Return on invested capital (5,493.45%) 0.00% 0.00%

Growth

Metric DMTKQ TTOO Diagnostics & Research median
Revenue growth (TTM) 9.71% (30.19%) 8.99%
EPS growth (last fiscal year) 20.36% 98.44% 20.36%
Revenue growth, 5-year CAGR 44.33% (7.29%) 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMTKQ TTOO Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 3.53 0.40 2.27
Net debt to EBITDA 0.57 0.32 0.68

Dividend

Metric DMTKQ TTOO Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric DMTKQ TTOO Diagnostics & Research median
Market cap 3.29m 6.48m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack